The scientist’s investigation covers issues in Microbiology, Meropenem, Klebsiella pneumoniae, Imipenem and Drug resistance. His Microbiology study combines topics in areas such as Pseudomonas aeruginosa and Beta-lactamase. His studies in Meropenem integrate themes in fields like Ceftazidime and Metallo β lactamase.
Spyros Pournaras has researched Klebsiella pneumoniae in several fields, including Plasmid, Antimicrobial, Colistin, Cefepime and Case-control study. His Drug resistance research is multidisciplinary, incorporating perspectives in Outbreak, Antibacterial agent, Acinetobacter baumannii and Genotype. His Genotype research is multidisciplinary, incorporating elements of Internal medicine, Antibiotic resistance and Mobile genetic elements.
Microbiology, Imipenem, Meropenem, Acinetobacter baumannii and Klebsiella pneumoniae are his primary areas of study. His Microbiology research includes elements of Pseudomonas aeruginosa, Gene and Virology. His Meropenem research integrates issues from Agar dilution and Carbapenem.
His Acinetobacter baumannii research is multidisciplinary, relying on both Molecular epidemiology, Neisseriaceae, Allele and Pulsed-field gel electrophoresis. His Klebsiella pneumoniae study incorporates themes from Cefotaxime, Cefepime, Enterobacteriaceae and Beta-lactamase. The study incorporates disciplines such as Antibiotic resistance and Genotype in addition to Drug resistance.
The scientist’s investigation covers issues in Microbiology, Internal medicine, Outbreak, Meropenem and Pulsed-field gel electrophoresis. His Microbiology research includes themes of Multilocus sequence typing, Acinetobacter baumannii and Virulence. His research in Internal medicine intersects with topics in Endocrinology and Surgery.
His Meropenem study combines topics from a wide range of disciplines, such as Klebsiella pneumoniae and Imipenem. His Imipenem research incorporates elements of Efflux, Pathogen and Carbapenem. His Pulsed-field gel electrophoresis course of study focuses on Agar dilution and Outpatient clinic and Klebsiella oxytoca.
His primary areas of investigation include Microbiology, Internal medicine, Klebsiella pneumoniae, Meropenem and Acinetobacter baumannii. His research ties Gram and Microbiology together. His Internal medicine study integrates concerns from other disciplines, such as Surgery and Intensive care.
His work carried out in the field of Meropenem brings together such families of science as Carbapenem and Imipenem. His Imipenem research incorporates themes from Enterobacteriaceae and Typing. He usually deals with Acinetobacter baumannii and limits it to topics linked to Molecular epidemiology and Lineage, Mobile genetic elements, Antibiotic resistance and Drug resistance.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues
V. Miriagou;G. Cornaglia;M. Edelstein;I. Galani.
Clinical Microbiology and Infection (2010)
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages.
Raffaele Zarrilli;Spyros Pournaras;Maria Giannouli;Athanassios Tsakris.
International Journal of Antimicrobial Agents (2013)
Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment.
O. Zarkotou;S. Pournaras;P. Tselioti;V. Dragoumanos.
Clinical Microbiology and Infection (2011)
Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece.
Athanassios Tsakris;Spyros Pournaras;Neil Woodford;Marie-France I. Palepou.
Journal of Clinical Microbiology (2000)
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Belén Gutiérrez-Gutiérrez;Elena Salamanca;Marina de Cueto;Po-Ren Hsueh.
Lancet Infectious Diseases (2017)
Defining Fractional Inhibitory Concentration Index Cutoffs for Additive Interactions Based on Self-Drug Additive Combinations, Monte Carlo Simulation Analysis, and In Vitro-In Vivo Correlation Data for Antifungal Drug Combinations against Aspergillus fumigatus
Joseph Meletiadis;Spyros Pournaras;Emmanuel Roilides;Thomas J. Walsh.
Antimicrobial Agents and Chemotherapy (2010)
A simple phenotypic method for the differentiation of metallo-β-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates
Athanassios Tsakris;Aggeliki Poulou;Spyros Pournaras;Evangelia Voulgari.
Journal of Antimicrobial Chemotherapy (2010)
Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit
S. Pournaras;A. Markogiannakis;A. Ikonomidis;L. Kondyli.
Journal of Antimicrobial Chemotherapy (2006)
Evaluation of Boronic Acid Disk Tests for Differentiating KPC-Possessing Klebsiella pneumoniae Isolates in the Clinical Laboratory
Athanassios Tsakris;Ioulia Kristo;Aggeliki Poulou;Katerina Themeli-Digalaki.
Journal of Clinical Microbiology (2009)
Prognostic value of follicular fluid 25-OH vitamin D and glucose levels in the IVF outcome
Georgios M Anifandis;Konstantinos Dafopoulos;Christina I Messini;Nektarios Chalvatzas.
Reproductive Biology and Endocrinology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: